HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria. - Wikidata - wikimedia - TriplyDB

HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

http://www.wikidata.org/entity/Q34313611

about

Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda Trends and determinants of HIV/AIDS knowledge among women in Bangladesh.An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda.Factors influencing mothers' decision to enroll their HIV-negative children in a hypothetical HIV vaccine trial.Factors associated with knowledge and awareness of HIV/AIDS among married women in Bangladesh: evidence from a nationally representative survey

P2860

Q30223510-87E32B90-4C83-45FC-B7A2-31BFF40F3997 Q35719108-768BC03B-E6C7-402A-9691-DC90DF2BC17B Q35863340-1B221E9C-16BD-492C-B39C-F8598F421271 Q36106313-CA1BCBE6-5C8C-4623-9202-72A6F66EF30A Q36218713-EE39917B-3AAF-4EE0-A331-632AFD43BD66 Q36777020-E46F137A-8822-4458-B604-AE5411A40690 Q37039342-594ED670-81DC-481F-BDB6-F6982148E27C Q38649549-80F84C7F-5F6D-47CD-A6EE-45FFCE2A1135 Q57924993-BD8C0DB6-E350-409D-BE56-011C6FF7B314

P2860

HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

http://www.wikidata.org/entity/Q34313611

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@ast

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@en

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@nl

type

label

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@ast

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@en

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@nl

prefLabel

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@ast

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@en

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@nl

P1433

Q34313611-B3DF2EFB-3C2A-4AFE-B2BA-1947C9F43E92

P1476

Q34313611-4353E21D-B8F9-4017-ABF6-3CE93E9EBD99

P2093

Q34313611-49B0A4EF-149B-47DC-8C52-431390334D57

Q34313611-546C349C-9943-48DE-900B-E8E447E92A69

Q34313611-676B7FC7-B674-4C9C-90D1-B3B39071FF76

Q34313611-B49BE33E-B7F8-4567-8289-7E675EECA567

Q34313611-D1779AB0-6AD4-4D75-BDF7-16628E4D0DDB

Q34313611-D1B9E11A-6EAC-41D0-9382-8BF979A16827

Q34313611-E47350D7-C55C-479C-9F6B-48B02669B51E

Q34313611-E86B790E-4187-412B-BAE7-F13E2F92F5A9

P2860

Q34313611-051FC2D0-5DBC-4558-A3C2-75A0234EBBC5

Q34313611-0A72E5FF-FF1F-406C-918D-C9C90D70F878

Q34313611-0C4BE0F9-5CFE-4359-BEF2-E85585E3BDEA

Q34313611-0F52C34F-C659-4B37-A47C-92EADF58C755

Q34313611-13298AE0-A27E-41B7-BEE9-290B75E3DCCF

Q34313611-14E14F78-A0B9-436D-BB78-FDB3CC8BFCAF

Q34313611-330154CC-7F0A-4A0F-B750-B1B68F2E3433

Q34313611-3E414641-7E12-469E-90D2-6B2114A31D16

Q34313611-456EB234-E41C-49D8-A7A8-43F05621835A

Q34313611-4E91B584-3660-495D-8EF7-C4F5C6D91320

P304

Q34313611-F488094A-4C61-4C2A-929A-AAF50434FD3E

P31

Q34313611-CC2943D2-9839-4D5C-B759-B923D87E11BF

P356

Q34313611-A2F78C6C-339E-421B-B2F2-656B24C0C592

P433

Q34313611-DDFCB681-31ED-4A90-8728-8684201D3657

P478

Q34313611-88D974DB-9D6F-495B-99A2-FCAFD11EC5C1

P577

Q34313611-B8CB6452-4D20-4C02-B6EE-66EE69299534

P5875

Q34313611-40271024-423D-4229-90C2-3E768CA8682E

P698

Q34313611-CC34B4B1-E05B-4876-AA33-64DEA2AEEE0D

P921

Q34313611-646BB824-93A6-42E2-968E-A70960345024

P932

Q34313611-90F7BEF4-8EE8-47B0-8F70-C8B1498D253E

P356

09540121003692219

P1433

P1476

HIV infection awareness and wi ...... risk groups in Abuja, Nigeria.

@en

P2093

Abdulsalami Nasidi

http://www.w3.org/2001/XMLSchema#string

Ahmed Saidu

http://www.w3.org/2001/XMLSchema#string

Alash'le Abimiku

http://www.w3.org/2001/XMLSchema#string

Gambo Aliyu

http://www.w3.org/2001/XMLSchema#string

Man Charurat

http://www.w3.org/2001/XMLSchema#string

Mukhtar Mohammad

http://www.w3.org/2001/XMLSchema#string

Prosanta Mondal

http://www.w3.org/2001/XMLSchema#string

William Blattner

http://www.w3.org/2001/XMLSchema#string

P2860

The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Willingness to participate in HIV vaccine research in a peri-urban South African community.

Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team.

Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.

Assessment of the changing willingness to participate in phase III HIV vaccine trials among men who have sex with men.

Sequence analysis of the glycoprotein 120 coding region of a new HIV type 1 subtype A strain (HIV-1IbNg) from Nigeria.

Willingness to participate in HIV vaccine trials: the impact of trial attributes.

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans.

P304

1277-1284

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09540121003692219

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45367393

http://www.w3.org/2001/XMLSchema#string

P698

20661789

http://www.w3.org/2001/XMLSchema#string

P921

P932

2982143

http://www.w3.org/2001/XMLSchema#string